正常血糖値女性におけるグルコース依存性インスリン分泌刺激ポリペプチドと活性アディポネクチンの関連
Isidora Salvatierra1, Javier Parada2, Rodrigo Cataldo3
1Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Endocrine connections
|January 13, 2026
まとめ
グルコース依存性インスリン分泌刺激ポリペプチド(GIP)レベルは、肥満マーカーおよび炎症と相関する。食後GIPは、肥満がない場合でも、脂肪症に関連する代謝問題のバイオマーカーとして可能性を示す。
科学分野:
- 内分泌学
- 代謝健康
- 肥満研究
背景:
- グルコース依存性インスリン分泌刺激ポリペプチド(GIP)は、栄養摂取後に腸内分泌K細胞から分泌される。
- GIPは、グルコース恒常性と栄養代謝において役割を果たす。
- GIPと肥満および炎症との関連を理解することは、代謝健康研究にとって重要である。
研究 の 目的:
- 経口ブドウ糖負荷に対する血漿GIP応答と、肥満関連の身体測定値、炎症マーカー、およびアディポカインとの横断的関連を評価すること。
- 食後血漿GIPを脂肪症関連表現型のバイオマーカーとして使用する実現可能性を評価すること。
主な方法:
- 正常血糖値で肥満のない50人の女性が経口ブドウ糖負荷試験(OGTT)を受けた。
- 8人の女性のサブセットが、デンプンベースの食事を用いた実現可能性研究に参加した。
- 空腹時および食後の血漿GIP、ホルモン、代謝物、アディポカイン、および炎症性バイオマーカーを測定した。
主要な成果:
- OGTT後のGIPの増加変化は、腹囲、空腹時TNF-α、および白血球数と相関した。
- 増加GIP変化と空腹時高分子量(HMW)アディポネクチンの間には、有意な逆の関連が観察された。
- これらの関連は、年齢とBMIで調整した後も有意であった。
結論:
- 食後GIPレベルは、循環HMWアディポネクチンと逆の関連がある。
- 食後血漿GIPは、肥満のない個人においても、脂肪症の増加に関連する代謝障害の適切なバイオマーカーである。
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K
Glucagon-like Receptor Agonists
836
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
836
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575


